Kkalpana Industries India Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of KKalpana Industries (India) Ltd is ₹ 7.95 as of 17 Feb 15:30 . The P/E Ratio of KKalpana Industries (India) Ltd is 8.6 as of March 2021 .The P/E Ratio of Saroja Pharma Industries India Ltd is 0 as of March 2021 . The Market Cap of KKalpana Industries (India) Ltd is ₹ 205.55 crore as of March 2021 .The Market Cap of Saroja Pharma Industries India Ltd is ₹ 0 crore as of March 2021 . The revenue of KKalpana Industries (India) Ltd for the Dec '25 is ₹ 11.15 crore as compare to the Sep '25 revenue of ₹ 12.72 crore. This represent the decline of -12.34% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of KKalpana Industries (India) Ltd for the Dec '25 is ₹ 0.8 crore as compare to the Sep '25 ebitda of ₹ 0.72 crore. This represent the growth of 11.11% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of KKalpana Industries (India) Ltd changed from ₹ 0.27 crore to ₹ 0.01 crore over 7 quarters. This represents a CAGR of -84.79% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of KKalpana Industries (India) Ltd changed from 8.39 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About KKalpana Industries (India) Ltd

Kalapana industries (India) Ltd was incorporated in September, 1985.
In priority, the Company was engaged in the business of manufacturing of PVC & XLPE Compounds and Embroidery of Fabrics.
Post Amalgamation, the Company recycles plastic and manufactures plastic granules.
It has 2 manufacturing units with state-of-the-art machinery, infrastructure, equipment, and R&D facilities.
With plants located at East Coast of India, the Company gains advantage of low freight costs. The company chalked out an expansion project at a cost of Rs.5 crores to increase the production capacities of XLPE. The commercial production is expected during the financial year of 2003-04. The Scheme of Amalgamation of KaIpana Plastics Pvt Ltd (KPPL) with the Company was made effective on 14 November, 2005.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of KKalpana Industries (India) Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, KKalpana Industries (India) Ltd or Saroja Pharma Industries India Ltd?

Market cap of KKalpana Industries (India) Ltd is 209 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr

What are the key factors driving the stock performance of KKalpana Industries (India) Ltd and Saroja Pharma Industries India Ltd?

The stock performance of KKalpana Industries (India) Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for KKalpana Industries (India) Ltd and Saroja Pharma Industries India Ltd?

As of March 23, 2026, the KKalpana Industries (India) Ltd stock price is INR ₹22.25. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹28.15.

How do dividend payouts of KKalpana Industries (India) Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of KKalpana Industries (India) Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.